Medical Affairs is uniquely positioned as the only department capable of impacting the Enterprise Commercialization Process (ECP) at every stage, from the initial product concept through the entire commercialization effort.
This article explores how Sumitomo Pharma America (SMPA) leveraged H1’s advanced data capabilities to integrate diverse insights, enhance field medical strategies, and foster cross-functional collaboration across therapeutic areas.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
Experts from Pfizer and Veeva explore a recent Veeva Pulse Report showing that targeted scientific outreach is associated with 40% faster treatment adoption.
This webinar, hosted by the MAPS APAC Chapter, aims to provide a comprehensive and practical overview of how Artificial Intelligence (AI) can be integrated into various functions of Medical Affairs. Attendees will gain insights into the application of AI in medical strategy, note-taking during advisory boards, setting agendas, and enhancing scientific communication. By the end of the session, participants will have a clear understanding of the tools and techniques available, and how to implement them effectively to improve efficiency and outcomes in their roles.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.
Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.
In this discussion, you’ll learn:
From the Spreadsheet Age to the Age of Generative AI: Where is your organization on the continuum of Insights Management? (And why no one “age” fits the needs of all teams.)
This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches. Learn from industry experts about the strategic goals of Medical Affairs and its unique impact generation in a cross-functional environment. Discover essential metrics for assessing performance and best practices for implementation. Explore cutting-edge data generation methods and technological advancements to enhance data quality and impact measurement.
Key topics to be addressed include:
What is the strategic goal of Medical Affairs and how does it generate impact?
What are the key metrics to measure Medical Affairs’ performance and impact?
How can innovative data approaches enhance measuring Medical Affairs’ impact?